Showing results (181-190 of 194) with videos related to
Sort By:
Pageof 20
The New England Journal of Medicine|November 24, 2020
A Randomized Trial of Convalescent Plasma in Covid-19 Severe PneumoniaVentura A Simonovich, Leandro D Burgos Pratx, Paula Scibona, et al.BMC Pregnancy and Childbirth|August 30, 2025
Zika in Infants and Pregnancy (ZIP) study: results from a prospective international cohort study of prenatal Zika virus infection and adverse fetal and infant outcomesJill Farnell Lebov, Martha Nason, Kristen B Stolka, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2024
Neutralizing Antibody Immune Correlates for a Recombinant Protein Vaccine in the COVAIL TrialYouyi Fong, Lauren Dang, Bo Zhang, et al.Science Translational Medicine|April 19, 2023
Comparing antibody assays as correlates of protection against COVID-19 in the COVE mRNA-1273 vaccine efficacy trialDavid Benkeser, David C Montefiori, Adrian B McDermott, et al.Eclinicalmedicine|July 5, 2022
Safety and immunogenicity of an HIV-1 prefusion-stabilized envelope trimer (Trimer 4571) vaccine in healthy adults: A first-in-human open-label, randomized, dose-escalation, phase 1 clinical trialKatherine V Houser, Martin R Gaudinski, Myra Happe, et al.Nature Communications|March 12, 2024
Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on Spike sequence featuresCraig A Magaret, Li Li, Allan C deCamp, et al.Nature Communications|January 17, 2025
Neutralizing antibody immune correlates in COVAIL trial recipients of an mRNA second COVID-19 vaccine boostBo Zhang, Youyi Fong, Lauren Dang, et al.Viruses|October 28, 2023
Stochastic Interventional Vaccine Efficacy and Principal Surrogate Analyses of Antibody Markers as Correlates of Protection against Symptomatic COVID-19 in the COVE mRNA-1273 TrialYing Huang, Nima S Hejazi, Bryan Blette, et al.Annals of Internal Medicine|September 30, 2024
National Institutes of Health COVID-19 Treatment Guidelines Panel: Perspectives and Lessons LearnedRoy M Gulick, Alice K Pau, Eric Daar, et al.Nature Communications|November 12, 2024
Neutralizing antibody correlate of protection against severe-critical COVID-19 in the ENSEMBLE single-dose Ad26.COV2.S vaccine efficacy trialLindsay N Carpp, Ollivier Hyrien, Youyi Fong, et al.Pageof 20